Author:
Sorensen Per Soelberg,Sellebjerg Finn
Reference11 articles.
1. Current evidence and therapeutic strategies for multiple sclerosis;Wingerchuk;Semin Neurol,2008
2. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study;Kappos;Lancet,2008
3. Fumaric acid esters, their place in the treatment of psoriasis;Ormerod;Br J Dermatol,2004
4. Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study;Schimrigk;Eur J Neurol,2006
5. Activation of Nrf2 and modulation of disease progression in EAE models by BG00012 (dimethyl fumarate) suggests a novel mechanism of action combining anti-inflammatory and neuroprotective modalities;Lukashev;Mult Scler,2007
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献